The macrolide drug erythromycin does not protect the hERG channel from inhibition by thioridazine and terfenadine.

Physiological Reports
Aziza El HarchiJules C Hancox

Abstract

The macrolide antibiotic erythromycin has been associated with QT interval prolongation and inhibition of the hERG-encoded channels responsible for the rapid delayed rectifier K+ current I(Kr ). It has been suggested that low concentrations of erythromycin may have a protective effect against hERG block and associated drug-induced arrhythmia by reducing the affinity of the pore-binding site for high potency hERG inhibitors. This study aimed to explore further the notion of a potentially protective effect of erythromycin. Whole-cell patch-clamp experiments were performed in which hERG-expressing mammalian (Human Embryonic Kidney; HEK) cells were preincubated with low to moderate concentrations of erythromycin (3 or 30 µM) prior to whole-cell patch clamp recordings of hERG current (IhERG ) at 37°C. In contrast to a previous report, exposure to low concentrations of erythromycin did not reduce pharmacological sensitivity of hERG to the antipsychotic thioridazine and antihistamine terfenadine. The IC50 value for IhERG tail inhibition by terfenadine was decreased by ~32-fold in the presence of 3 µM erythromycin (p < .05 vs. no preincubation). Sensitivity to thioridazine remained unchanged (p > .05 vs. no preincubation). The effects ...Continue Reading

References

Sep 1, 1994·British Journal of Clinical Pharmacology·K Na-BangchangJ Karbwang
Nov 1, 1994·The American Journal of Emergency Medicine·D G ParisA P Niarchos
Feb 1, 1994·The Annals of Pharmacotherapy·K E BiglinM Lieh-Lai
Sep 1, 1996·Pflügers Archiv : European journal of physiology·A J LeviJ Vinnicombe
Aug 22, 2000·British Journal of Pharmacology·H TieT J Campbell
May 8, 2001·Trends in Pharmacological Sciences·J I VandenbergT J Campbell
Apr 19, 2002·The Journal of Biological Chemistry·Jose A Sánchez-ChapulaMichael C Sanguinetti
May 4, 2002·Circulation Research·Kazutaka Gima, Yoram Rudy
Jun 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Walter A VolbergJun Zhou
Jul 4, 2003·British Journal of Pharmacology·John S Mitcheson
Jul 4, 2003·British Journal of Pharmacology·James T MilnesHarry J Witchel
Oct 7, 2003·Pain·Craig A KornickPaolo L Manfredi
Nov 5, 2003·Heart·Yee Guan Yap, A John Camm
Dec 17, 2003·Molecular and Cellular Biochemistry·Scott J C StanatCraig W Clarkson
Mar 17, 2004·Cardiovascular Research·Juan TamargoEva Delpón
May 12, 2004·Journal of Molecular and Cellular Cardiology·John M RidleyJules C Hancox
Sep 4, 2004·Psychosomatics·W Victor R Vieweg, Mark A Wood
Jun 1, 2005·Journal of Pharmacological and Toxicological Methods·Joffrey DucroqMarie Le Grand
Jul 14, 2005·Biochemical and Biophysical Research Communications·Mark J McPateJules C Hancox
Feb 1, 2006·Biochemical and Biophysical Research Communications·Rona S DuncanHarry J Witchel
Mar 24, 2006·Nature·Michael C Sanguinetti, Martin Tristani-Firouzi
Oct 24, 2006·Biochemical and Biophysical Research Communications·James T MilnesJules C Hancox
Apr 21, 2007·Proteins·Phillip J StansfeldMichael J Sutcliffe
Jun 27, 2007·British Journal of Pharmacology·D StorkS Hering
May 14, 2008·Journal of Cardiovascular Pharmacology·Michael Margulis, Steve Sorota
Jul 12, 2008·Pharmacology & Therapeutics·Jules C HancoxYi Hong Zhang
Nov 11, 2008·The Journal of Biological Chemistry·Pengchu JuJamie I Vandenberg
Jan 15, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Anne Friemel, Bernd J Zünkler
Feb 23, 2010·Journal of Pharmacological and Toxicological Methods·James T MilnesJules C Hancox
Jul 23, 2011·Biochimica Et Biophysica Acta·Yi H ZhangJules C Hancox
Oct 13, 2011·Journal of Molecular and Cellular Cardiology·Aziza El HarchiJules C Hancox
Jun 14, 2013·Journal of Pharmacology & Pharmacotherapeutics·Shailaja B KhobragadeVyas M Shingatgeri
Sep 18, 2013·European Journal of Pharmacology·Jing MengYanfang Xu
Aug 29, 2014·Therapeutic Advances in Infectious Disease·Jules C HancoxAdrian Baranchuk

❮ Previous
Next ❯

Citations

May 21, 2020·Frontiers in Cardiovascular Medicine·Alexander CarpenterAndrew F James
Nov 3, 2021·Cellular and Molecular Life Sciences : CMLS·Ehab Al-MoubarakJules C Hancox

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
transfection
transfections

Software Mentioned

GraphPad Prism
Sigmaplot
WinWCP

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Ugeskrift for laeger
P KjaeldgaardH Colding
Pediatrics in Review
F Shah
Bollettino chimico farmaceutico
C TOSI
Deutsche medizinische Wochenschrift
W Dölle
© 2021 Meta ULC. All rights reserved